iBio IBIO
iBio reports $7.55 million net loss for fiscal Q1 2027
iBio (IBIO) filed a 10-Q with the SEC on Nov 10, 2026, 4:39 pm ET. Source: the filing on SEC EDGAR.
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0001420720-26-000036
- Revenue: $1.08 million for the three months ended Sep 30, 2026
- Net loss: $7.55 million for the three months ended Sep 30, 2026
- Cash and equivalents: $45.44 million at Sep 30, 2026
Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.
What changed since last quarter
1 new risk factor · 4 removed
Compared with the 10-Q for the period ended Mar 31, 2026.
| This filing | Previous | Change vs prior 10-Q | |
|---|---|---|---|
| Revenue | $1.08M | $0 | — |
| Operating income and margin | −$8.34M | −$11.38M | +27% |
| Net income | −$7.55M | −$10.6M | +29% |
| Operating cash flow | −$9.39M | −$6.23M | −51% |
| Cash | $45.44M | $56.4M | −19% |
New risk factors (1)
- As of the date of this Quarterly Report, up to 102,942,358 shares of Common Stock are issuable upon the exercise of the warrants issued or issuable in connection with the August 2025 underwritten public offering, the issuance of which will result in substantial dilution to the existing holders of our Common Stock and…
Removed risk factors (4)
- ● initiate clinical trials of our product candidates which we plan to commence in the second quarter of calendar year 2026;
- We will need additional funding to fully execute our business plan, which funding may not be available on commercially acceptable terms or at all. If we are unable to raise capital when needed, we may be forced to delay, reduce or eliminate the commercialization of our development and manufacturing services and… +3 more paragraphs
- As of March 31, 2026, up to 89,042,863 shares of Common Stock are issuable upon the exercise of pre-funded warrants, with an exercise price of $0.001, and up to 38,555,185 shares of Common Stock are issuable upon the exercise of outstanding warrants, the issuance of which will result in substantial dilution to the…
- A future shutdown of the U.S. federal government may adversely affect our business. +10 more paragraphs